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Background: For decades in Finland, intensive population strategies and preventive activities have been used to
lower the risk of atherosclerotic coronary heart disease (CHD). Lifestyle changes, with the emphasis on diet, play an
important role in preventive strategies. The aim of this study was to evaluate arterial stiffness and endothelial
function in asymptomatic free-living adults and to relate the results to CHD risk factors and lifestyle habits with the
emphasis on diet.
Methods: Ninety-four asymptomatic participants were recruited by advertisements in four large companies and
two research institutes employing mainly office workers. Arterial stiffness was assessed as the cardio-ankle vascular
index in large arteries, and endothelial function as the reactive hyperemia index with peripheral arterial tonometry.
The systematic Cardiovascular Risk Estimation (SCORE) was calculated.
Results: The data was collected in the spring of 2011. Anthropometric, dietary, and lipid data was available from 92
participants, blood pressure from 85 and vascular measurements from 86–88 subjects (38% males; 62% females; mean
age of all 51). The majority (72%) had an elevated low density lipoprotein (LDL) cholesterol concentration and over half
were overweight or obese. SCORE stated that 49% of the participants had a moderate risk of cardiovascular disease.
When compared to general recommendations, half of the participants had too high intake of total fat and in 66% the
consumption of saturated fat was too high. In contrast, the intake of carbohydrates was too low in 90% of the
participants and for fiber 73% were below recommendations. There was evidence of borderline or increased arterial
stiffness in 72% of the participants and endothelial function was impaired in 8%. Arterial stiffness was associated with
LDL cholesterol concentration (p = 0.024), dietary cholesterol intake (p = 0.029), and SCORE (p < 0.001).
Conclusions: In a cross-sectional study of asymptomatic middle-aged participants, the half had a moderate risk for
cardiovascular diseases manifested as increased arterial stiffness, elevated LDL cholesterol concentration, and poor
dietary habits. The new observation that arterial stiffness was associated with dietary cholesterol intake and SCORE
emphasizes the urgency of adequate lifestyle and dietary interventions to prevent future coronary events even in
asymptomatic participants.
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An elevated concentration of low-density lipoprotein
(LDL) cholesterol is a major risk factor for atheroscler-
otic coronary heart disease (CHD) [1]. When the LDL
cholesterol concentration is lowered by any means, then
the risk for CHD is reduced [1]. Artery health can be
evaluated non-invasively via surrogate markers i.e. arter-
ial stiffness [2-5] and endothelial function [6]. The main
beneficial lifestyle habits influencing the LDL cholesterol
concentration are 1) low intake of cholesterol and total
fats, especially those of saturated fats, 2) maintaining
normal body weight, 3) ensuring regular physical activity
[7]. It has been estimated that lowering the intake of
saturated fat (<7E%) and cholesterol (<200 mg/d) can re-
duce the serum cholesterol concentration by about 5%
[1]. The metabolic background of these effects has well
been characterized.
In Finland in the late 1960s, CHD mortality was spec-
tacularly high, especially in middle-aged men. Intensive
population strategies and preventive activities to pro-
mote changes in lifestyle habits were initiated and grad-
ually implemented throughout the entire country. The
outcome has been monitored systematically in large
population cohorts since 1972 by the Finnish National
Institute for Health and Welfare [8]. The mortality rates
declined in the whole population, especially in men by
up to 80% from 1972 until about 2007. About 60% of
this decline has been attributed to a reduction in the risk
factors (serum cholesterol concentration, blood pressure
and smoking). The lowered serum cholesterol concen-
tration alone explained 45% of the decline in CHD mor-
tality. Furthermore, the reduction in dietary fat and
cholesterol explained 60-65% of the change in serum
cholesterol concentration [9]. Reduced dietary saturated
fat intake explained over 40% and that of dietary choles-
terol about 9% of the serum cholesterol reduction. In
contrast, the impact of cholesterol lowering medication
was only 7-16%. In summary, dietary changes played a
significant role in CHD risk reduction. Since the pre-
ventive aspects had succeeded over the long-time at the
population level, the aim of the present study was to
evaluate in asymptomatic free-living adults the indicators
of vascular health and CHD risk factors. Furthermore, we
evaluated how well the lifestyle recommendations, with an
emphasis on diet, were followed in these participants in
relation to the LDL cholesterol concentration and arterial
stiffness and endothelial function.
Methods
Subjects
Ninety-four volunteers were screened and recruited into
this 6-month intervention called BLOOD FLOW in 2011
by advertisements in the walls or in the intranet of four
large companies employing mainly office workers and intwo research institutes. This study is presenting the base-
line data of the randomized, controlled, double-blind
intervention evaluating the effects of plant stanol ester on
cardiovascular health. The results of the intervention,
which was carried out in 2011, have been published re-
cently [10]. No inclusion or exclusion criteria for serum
and lipoprotein lipids were set, but lipid-lowering medica-
tion or the consumption of nutrient supplements interfer-
ing with serum cholesterol concentration (red rice or
berberine) were included as exclusion criteria. If the par-
ticipants had used plant sterol/stanol products, they could
be included in the study after a 3 weeks’ wash out
period, which is enough for the serum cholesterol con-
centration to be returned to its initial value [11,12].
Other exclusion criteria were current gravidity or breast
feeding, unstable coronary artery disease or coronary by-
pass or angioplasty <6 months, inflammatory bowel dis-
ease, alcohol consumption >45 g absolute alcohol/d, or
abnormal liver, kidney or thyroid function. Possible medi-
cation should have remained unchanged for one month
before the study. At recruitment, the participants con-
tacted the research personnel, and their eligibility to the
study was checked using a list of the exclusion criteria.
All participants screened were invited to participate in
the study. All data presented were collected from March
to May 2011 after randomization.
The study was performed according to the principles
of the Declaration of Helsinki. The Ethics Committee of
the Department of Medicine, Hospital District of Helsinki
and Uusimaa approved the study protocol. All participants
gave their written informed consent.
Measurements and laboratory analyses
Before blood samples were drawn body weight was mea-
sured with a digital scale and height with a stadiometer
without shoes and in light clothes. Body mass index
(BMI) was calculated as weight (kg) divided by height
squared (m2). Waist circumference was measured at a
level midway between the lowest rib and the iliac crest
by the measuring tape.
Fasting blood samples were drawn after a 12 hour-fast.
Plasma glucose and serum high-sensitive C-reactive pro-
tein (hs-CRP) concentrations were analyzed with routine
standardized methods at the Central Laboratory of
Helsinki University Hospital (HUSLAB). Serum total,
LDL and high-density lipoprotein (HDL) cholesterol and
serum triglycerides were analyzed enzymatically using
automated analyzer systems. The level of non-HDL chol-
esterol was calculated as follows: non-HDL cholesterol =
total cholesterol-HDL cholesterol.
Vascular measurements
After 10 minutes’ supine rest, blood pressure was mea-
sured manually (Boso, Germany). The cardio-ankle
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aortic pulse wave velocity (PWV) and pulse waveform
(Vasera VS-1500, Fukuda Denshi Co, Japan) by the
methods described elsewhere [4].
In short, PWV is obtained by dividing vascular length
by the time taken for the pulse wave to propagate from
the aortic valve to the ankle. CAVI is an index of arterial
stiffness representing the elastic properties of arterial
wall between aortic arch and distal arteries of the lower
extremities and is considered to be independent of blood
pressure at the time of measurement [2-5]. CAVI has
proven to be valid and reproducible [13,14]. In large
Japanese populations, CAVI ≥8 has been found to be an
index of increased arterial stiffness, and if CAVI ≥9, then
arterial stiffness can be considered as being significantly
increased [15]. However, European reference values have
not yet been published. CAVI has been proposed as be-
ing a surrogate marker for athero- or arteriosclerosis [4]
and it has also been used as an indicator of vascular
health during dietary modification [16].
Endothelial function was assessed with peripheral
arterial tonometry (PAT) (Endo-PAT2000, Software
version 3.0.3, Itamar Medical Ltd, Caesarea, Israel). The
reactive hyperemia index (RHI) assesses the peripheral
flow-induced arterial dilation after a provocation of re-
active hyperemia, and it is defined as the ratio of the
post-deflation pulse amplitude to the baseline pulse
amplitude. Low values of RHI (≤1.67) reflect endothelial
dysfunction [6]. The principal of PAT measurement has
been described elsewhere [17]. The PAT measurement
displays good reproducibility [18].Background questionnaire and nutrient intakes
Previous and present diseases, current drug treatment, use
of vitamins or other nutrient supplements and lifestyle
habits i.e. smoking habits, frequencies of alcohol con-
sumption as well as frequencies of fitness or functional
exercise were reviewed with a structured questionnaire.
All participants kept the 3-day food record between
March and May 2011. One of the consecutive recording
days was a weekend day. The portion sizes were esti-
mated using household measures. The dietician con-
tacted the participants by telephone and checked the
amounts and qualities of foods in the hand-filled food
records to clarify items that were unclear or missing.
The same person coded all food records. The nutri-
ents in food record were calculated by using the
Diet32 dietary analysis program-version 1.4.6.2 (Aivo
Ltd., Turku, Finland) which uses the Fineli® Food
Composition Database (National Institute for Health
and Welfare, Nutrition Unit, Helsinki, Finland). The
ratio of calculated energy intake to estimated energy
expenditure was 0.80 ± 0.20 indicating lower energyintake than the predicted one based on Schofield
equations and cut-off factor (1.49) [19].Systematic cardiovascular risk estimation
The Systematic Cardiovascular Risk Estimation (SCORE),
which estimates 10-year risk of fatal cardiovascular disease
(CVD), was calculated by using the score charts with low
risk based on following risk factors: age, sex, smoking, sys-
tolic blood pressure, and total cholesterol [20]. In addition,
HDL cholesterol was taken into account in risk evaluation
[21]. We defined “low risk” per SCORE guidelines as <1,
“moderate risk” as 1–4 and “high risk” as 5–9.Statistical analyses
Statistical analyses were performed with SPSS for Windows
19.0 statistics program (SPSS, Chicago, IL, USA). Normal-
ity and homogeneity of variance assumptions were checked
before further analyses. Logarithmic transformation was
performed for variables that were not normally distributed
or homogenous in variance.
In a large Japanese study, men had significantly greater
CAVI than women in all age classes except for 70–74 years
[22], therefore we assessed whether there were significant
differences in vascular measurements between gender. For
congruence we also assessed whether there were gender-
related differences in serum lipids and lipoproteins, nutri-
ent intake or other characteristics (Table 1).
Student’s t test was used to assess differences between
gender and univariate analysis of variance was used to as-
sess differences between the grades of artery stiffness for
continuous variables. Mann–Whitney U-test was used in
the gender-comparison and Kruskal-Wallis test was used
in the comparison of the grades of arterial stiffness for a
non-normally distributed variable (alcohol intake). The
differences between gender were further assessed using
analysis of covariance (ANCOVA) including variables that
significantly differed between gender as covariates
(see Table 1). Similarly, the differences between the grades
of arterial stiffness were assessed using ANCOVA includ-
ing the covariates described in Table 2.
Relationships between LDL cholesterol, hs-CRP, CAVI
and RHI as well as relationships between CAVI and RHI
and nutrient intakes were analyzed by Pearson correlation
test. In addition, the relationship between SCORE and
above variables was analyzed by the Spearman correlation
test. In addition, to evaluate the effects of gender and age
on associations of serum LDL cholesterol and CAVI, a
multiple linear regression analysis was used. Fisher exact
test was used for categorical measures. The Bonferroni ad-
justment was used to control the overall α level in mul-
tiple comparisons. A p-value of <0.05 was considered
statistically significant. The results are given as means ±
SEM, unless otherwise indicated.
Table 1 Characteristics of the participants and nutrient intakes
All (n = 92) Men (n = 35) Women (n = 57)
Age (y) 50.8 ± 1.0 49.0 ± 1.7 51.8 ± 1.2
BMI (kg/m2) 25.2 ± 0.4 26.3 ± 0.5 24.5 ± 0.5a
Waist circumference (cm) 88.8 ± 1.1 94.9 ± 1.6 85.0 ± 1.2a
Systolic blood pressure (mmHg) 122 ± 1 124 ± 2 121 ± 2
Diastolic blood pressure (mmHg) 76 ± 1 77 ± 1 75 ± 1
Blood glucose (mmol/l) 4.92 ± 0.06 5.06 ± 0.09 4.83 ± 0.07(a)
hs-CRP (mmol/l) 1.05 ± 0.09 0.71 ± 0.09 1.25 ± 0.13a
Total cholesterol (mmol/l) 5.53 ± 0.09 5.44 ± 0.14 5.58 ± 0.12
LDL cholesterol (mmol/l) 3.53 ± 0.09 3.65 ± 0.14 3.45 ± 0.12
HDL cholesterol (mmol/l) 1.78 ± 0.05 1.57 ± 0.07 1.90 ± 0.06a
Triglycerides (mmol/l) 0.93 ± 0.04 1.01 ± 0.08 0.88 ± 0.05
non-HDL cholesterol (mmol/l) 3.75 ± 0.10 3.87 ± 0.16 3.67 ± 0.13
CAVI 8.66 ± 0.11 8.46 ± 0.18 8.78 ± 0.14
RHI 2.22 ± 0.06 2.16 ± 0.09 2.27 ± 0.08
Energy (MJ/d) 7.8 ± 0.2 8.4 ± 0.4 7.5 ± 0.2
Protein (% of energy) 17.3 ± 0.3 18.4 ± 0.6 16.7 ± 0.4a
Fat (% of energy) 34.1 ± 0.7 32.9 ± 1.2 34.8 ± 0.8
SFA (% of energy) 11.4 ± 0.3 11.5 ± 0.6 11.3 ± 0.4
MUFA (% of energy) 11.8 ± 0.3 11.3 ± 0.5 12.1 ± 0.4
PUFA (% of energy) 5.6 ± 0.2 5.1 ± 0.3 5.9 ± 0.3a
Carbohydrates (% of energy) 41.5 ± 0.7 40.5 ± 1.3 42.2 ± 0.9
Alcohol (% of energy) 2.4 ± 0.3 3.7 ± 0.7 1.6 ± 0.3a
Cholesterol (mg/d) 222.6 ± 10.1 247 ± 18.2 207.7 ± 11.5a
Cholesterol (mg/MJ) 29.1 ± 1.4 30.1 ± 2.0 28.5 ± 1.8
Fiber (g/d) 21.3 ± 0.7 20.3 ± 1.2 21.8 ± 0.9
Fiber (g/MJ) 2.8 ± 0.1 2.5 ± 0.1 2.9 ± 0.1a
Values shown are means ± SEM. BMI = body mass index; CAVI = cardio-ankle vascular index; HDL-C: high density lipoprotein; hs-CRP = high sensitive C-reactive
protein; LDL: low density lipoprotein; MUFA: monounsaturated fatty acid; PUFA: polyunsaturated fatty acid; RHI: reactive hyperemia index; SFA: saturated
fatty acid.
n = 33/52 (men/women) for systolic and diastolic blood pressure, n = 34/54 for CAVI and n = 34/52 for RHI.
ap < 0.05 or less significantly different from men as analyzed by Student’s t-test or Mann–Whitney U-test (alcohol).
(a)p > 0.05 after adjustment with BMI, waist circumference, intakes of protein, PUFA, alcohol, cholesterol (mg/d) and fiber (g/MJ) as analyzed by analysis of covariance.
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Characteristics
Baseline data was available from 92 participants except
for blood pressure n = 85 and vascular measurements
n = 86-88 (Table 1) due to technical problems. The major-
ity of the participants (62%) were women. All participants
were aged between 24–66 years. The prevalence of dis-
eases, medication and, smoking habits are given in Table 2.
None of the participants had CHD or other cardiovascular
diseases. Of the fifteen participants with hypertension,
nine were taking regular medication. All participants with
a history of hypothyreosis were receiving thyroxin therapy
and were euthyreoid. Type 2 diabetes (n = 1) was con-
trolled by diet alone. The other diseases were under good
control or in remission. According to the questionnaire,25% of the participants took physical exercise four times
or more weekly, 44% two to three times weekly, 23% once
a week and 9% stated that they were physically inactive.
BMI, waist circumference and plasma glucose concen-
tration were higher and the serum hs-CRP and HDL
cholesterol concentrations lower in men than in women.
There were no significant gender differences in the other
clinical variables or frequencies of diseases or medica-
tions. The intakes of protein, alcohol and cholesterol
(mg/d) were higher and the intakes of polyunsaturated
fatty acids (PUFA) and fiber (g/d) lower in men than in
women, but there were no other differences in nutrient
intakes between the genders. The gender difference in
serum hs-CRP and HDL cholesterol concentrations
remained significant after adjustment with BMI, waist
Table 2 Diseases, medication and smoking in the
participants of the study
All
(n = 92)
Men
(n = 35)
Women
(n = 57)
Diseasesa
Hypertension (n) 15 4 11
Diabetes or impaired glucose
tolerance (n)
3 1 2
Cancer, remission (n) 6 3 3
Cholelithiasis (n) 2 0 2
Arthritis (n) 1 0 1
Celiac disease (n) 2 0 2
Hypothyreosis (n) 5 0 5
Asthma (n) 5 1 4
Hypertensiona
Calcium channel blockers (n) 3 1 2
Beta blockers (n) 2 0 2
Diuretics (n) 2 2 0
Angiotensin converting enzyme- or
angiotensin receptor blocking agents (n)
7 3 4
Hormonal medicationa
Thyroxin (n) 6 0 6
Contraceptives (n) 4 - 4
Hormone replacement therapy (n) 15 - 15
Smoking (n)a 7 5 2
aNo significant differences were found between the gender as analyzed by
Fisher exact test.
Figure 1 Distribution of participants within or outside of
recommended/reference value of different variables. BMI: body
mass index; BP: blood pressure; CAVI: cardio-ankle vascular index;
HDL-C: high density lipoprotein cholesterol; E%: percent of energy;
LDL-C: low density lipoprotein cholesterol; MUFA: monounsaturated
fatty acid; PUFA: polyunsaturated fatty acid; RHI: reactive hyperemia
index; SCORE: Systematic Cardiovascular Risk Estimation; SFA:
saturated fatty acid.
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i.e. protein, PUFA, alcohol, cholesterol and fiber.
Characteristics of the participants vs. reference values
BMI ranged from 17.9 to 36.6 kg/m2. About 47% of the
whole study population had normal weight (BMI <
25 kg/m2) and 53% were overweight or obese (BMI 25–
37 kg/m2) (Figure 1). The majority of the men (77%)
were overweight or obese as compared with the women
(39%) (χ2 = 12.943, p < 0.001). About one in four (26%)
of all participants had abdominal obesity (waist circum-
ference >102 cm in men and >88 cm in women).
Serum total and LDL cholesterol varied from 3.4 to
7.2 mmol/l and from 1.5 to 5.6 mmol/l. The mean values
are given in Table 1. Sixty-six participants had elevated
serum total (≥ 5.0 mmol/l [20,23]) and LDL cholesterol
(≥3.0 mmol/l [20,23]) concentrations (Figure 1). The
HDL cholesterol concentration was low in four men
(≤1.0 mmol/l [23]) and in two women (≤1.2 mmol/l
[23]) and that of triglycerides high (>1.7 mmol/l [23]) in
six participants. The magnitudes of the frequencies were
similar in men and women.
SCORE was in 51% of the participants below 1% (low
risk) whereas in 49% of the participants, the risk was 1-4%(moderate risk). In addition, 35 participants (84%) belong-
ing to low risk class had LDL cholesterol ≥2.5 mmol/l,
which requires to initiate lifestyle changes even in this risk
class [20]. None of the participants belonged to the high
risk group.
About 28% of the participants had normal arterial
stiffness (CAVI < 8), 31% had slightly elevated arterial
stiffness (CAVI 8–9) and 41% had elevated arterial stiff-
ness (CAVI >9 [15]) (Figure 1). Seven participants had
abnormal endothelial function (RHI ≤ 1.67 [6]) (Figure 1).
No gender differences were found in the frequencies in
CAVI or RHI groups.Dietary intakes vs. dietary recommendations
According to the current dietary recommendations, the
total fat intake was too high (25–35 percent of energy
(E%) [24]) in 46% of the participants, that of saturated
fatty acid (SFA) intake (<10E% [20,23,24]) in 66% of the
participants, and dietary cholesterol intake (<300 mg/d
[23] in 15% of the participants (Table 1 and Figure 1).
The dietary recommendation for monounsaturated fatty
acid (MUFA) intake (10-15E% [24]) was not being met
by 35% and that of PUFA intake (5-10E% [24]) by 46%
participants. The carbohydrate intake was less than
recommended (50-60E% [24]) in 90% of the participants
and in 39% it was less than 40E%. The recommendation
of fiber intake (25–35 g/d [24]) was not fulfilled in 73%
of the participants. No gender differences were found in
nutrient intakes vs. dietary recommendations.
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When participants were divided according to their arter-
ial stiffness (Table 3), it was noted that age and systolic
blood pressure were lower in the participants with
CAVI < 8 and CAVI 8–9 and the diastolic blood pressure
was lower in the participants with CAVI 8–9 as com-
pared with the participants with CAVI > 9. In addition,
energy intake was greater, but cholesterol (mg/MJ) in-
take lower in those participants with CAVI < 8 compared
with the participants with CAVI > 9. After adjustment
for gender, age and the intakes of energy and cholesterol
(mg/MJ), it was found that systolic blood pressure wasTable 3 Characteristics of the participants and nutrient intake
CAVI < 8 (n = 25)
Men/women (n) 11/14
Age (y) 43.6 ± 1.9
BMI (kg/m2) 24.8 ± 0.7
Waist circumference (cm) 86.9 ± 1.8
Systolic blood pressure (mmHg) 120 ± 2
Diastolic blood pressure (mmHg) 75 ± 1
Blood glucose (mmol/l) 4.75 ± 0.09
hs-CRP (mmol/l) 0.74 ± 0.13
Total cholesterol (mmol/l) 5.24 ± 0.20
LDL cholesterol (mmol/l) 3.26 ± 0.16
HDL cholesterol (mmol/l) 1.79 ± 0.09
Triglycerides (mmol/l) 0.77 ± 0.07
non-HDL cholesterol (mmol/l) 3.45 ± 0.17
CAVI 7.34 ± 0.11
RHI 2.15 ± 0.13
Energy (MJ/d) 8.7 ± 0.4
Protein (% of energy) 17.6 ± 0.8
Fat (% of energy) 33.2 ± 1.1
SFA (% of energy) 11.6 ± 0.6
MUFA (% of energy) 11.0 ± 0.5
PUFA (% of energy) 5.4 ± 0.3
Carbohydrates (% of energy) 42.2 ± 1.2
Alcohol (% of energy) 2.2 ± 0.8
Cholesterol (mg/d) 209.0 ± 16.9
Cholesterol (mg/MJ) 23.9 ± 1.4
Fiber (g/d) 22.3 ± 1.4
Fiber (g/MJ) 2.6 ± 0.1
Values shown are means ± SEM. BMI = body mass index; CAVI = cardio-ankle vascula
protein; LDL: low density lipoprotein; MUFA: monounsaturated fatty acid; PUFA: pol
CAVI < 8 depicts normal arterial stiffness; CAVI 8–9 depicts slightly elevated arterial
n = 24/27/34 (CAVI < 8/8-9/>9) for systolic and diastolic blood pressure, n = 25/27/36
ap < 0.05 from the participants with CAVI < 8 as analyzed by univariate analysis of v
and the intakes of energy and cholesterol (mg/MJ) systolic blood pressure did not d
bp < 0.05 from the participants with CAVI 8–9 as analyzed by univariate analysis of v
and the intakes of energy and cholesterol (mg/MJ) diastolic blood pressure did notstill lower in the participants with CAVI 8–9 as com-
pared with the participants with CAVI > 9.
Associations
LDL cholesterol and CAVI were positively associated
with age (r = 0.244, p = 0.019 and r = 0.667, p < 0.001, re-
spectively) and CAVI tended to correlate with hs-CRP
(r = 0.205, p = 0.055). The LDL cholesterol concentration
was associated with CAVI (r = 0.240, p = 0.024), espe-
cially in the participants with the elevated LDL choles-
terol ≥3 mmol/l [20,23] (r = 0.305, p = 0.030 vs. LDL
cholesterol <3 mmol/l r = 0.169, p = 0.838). However,s related to arterial stiffness
CAVI 8–9 (n = 27) CAVI > 9 (n = 36)
12/15 11/25
48.2 ± 1.5 57.1 ± 1.0a,b
25.3 ± 0.8 25.3 ± 0.5
90.4 ± 2.4 89.0 ± 1.5
117 ± 2 128 ± 2(a),b
73 ± 1 79 ± 1(b)
4.96 ± 0.12 5.00 ± 0.09
1.09 ± 0.17 1.14 ± 0.16
5.44 ± 0.15 5.72 ± 0.14
3.52 ± 0.16 3.70 ± 0.16
1.71 ± 0.08 1.76 ± 0.08
0.99 ± 0.10 1.00 ± 0.07
3.73 ± 0.17 3.96 ± 0.17
8.60 ± 0.05a 9.62 ± 0.09a,b
2.10 ± 0.08 2.38 ± 0.09
7.9 ± 0.4 7.2 ± 0.3a
17.5 ± 0.7 17.2 ± 0.5
33.7 ± 1.4 35.1 ± 1.1
10.9 ± 0.5 11.7 ± 0.6
11.7 ± 0.8 12.4 ± 0.5
5.6 ± 0.4 5.7 ± 0.3
41.8 ± 1.5 40.9 ± 1.1
2.4 ± 0.7 2.2 ± 0.5
214.3 ± 20.5 234.6 ± 16.6
26.8 ± 2.1 33.7 ± 2.7a
21.7 ± 1.3 20.3 ± 1.1
2.8 ± 0.2 2.9 ± 0.1
r index; HDL-C: high density lipoprotein; hs-CRP = high sensitive C-reactive
yunsaturated fatty acid; RHI: reactive hyperemia index; SFA: saturated fatty acid
stiffness; CAVI > 9 depicts markedly elevated arterial stiffness.
for CAVI and n = 25/27/34 for RHI.
ariance with Bonferroni correction. (a)p > 0.05 after adjustment for age, gender
iffer from the participants with CAVI < 8.
ariance with Bonferroni correction. (b)p > 0.05 after adjustment for age, gender
differ from the participants with CAVI 8–9.
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ment for gender and age. LDL cholesterol and RHI were
not correlated with each other. CAVI was positively
associated with dietary cholesterol (mg/MJ/d) intake
(r = 0.233 p = 0.029) even after adjustment for gender
and age (β = 0.200, p = 0.016). CAVI was not associated
with any other nutrient intake. RHI was neither associ-
ated with nutrient intakes nor with CAVI.
SCORE was positively correlated with LDL cholesterol
(r = 0.251, p = 0.020) and CAVI (r = 0.368, p < 0.001).
SCORE was not correlated with RHI (r = 0.054, p = 0.621).
Discussion
The novel observations in the present study were that
the majority (72%) of asymptomatic middle-aged partici-
pants had elevated LDL cholesterol concentration, over
half were overweight or obese, and 72% displayed bor-
derline or increased arterial stiffness. As assessed with
the SCORE [20,21], only half of the participants could
be categorized into the low risk group, and furthermore
when the LDL cholesterol concentration was taken into
consideration, then only seven individuals could be con-
sidered as real low-risk persons who would not benefit
from lifestyle intervention. The SCORE was associated
with arterial stiffness. Regarding the risk patterns of this
study population, it can be stated that their dietary
habits were far from ideal. Over two thirds were con-
suming too much saturated fat, 90% consumed too little
carbohydrates, and about 70% too little fiber. Of the
other lifestyle habits, although only 8% of the partici-
pants were current smokers, for the vast majority phys-
ical activity did not reach the recommended levels [24].
These results suggest that a large number of the
asymptomatic participants had increased CHD risk fac-
tors and increased arterial stiffness. This finding may re-
flect the same phenomenon observed in a recent survey
conducted by the Finnish National Institute for Health
and Welfare, which demonstrated that in 2012, the
serum cholesterol concentrations have increased from
those values observed in 2007. This represents the end
of what has been a beneficial trend which started de-
cades ago [8,25]. The recent European guidelines on
cardiovascular disease prevention in clinical practice
emphasize that a healthy diet is the cornerstone of car-
diovascular disease prevention e.g. SFA intake should
not be more than 10% of total energy intake [20,26].
Furthermore, according to European guidelines, func-
tional foods containing phytosterols (plant sterols and
stanols) can effectively lower LDL cholesterol levels by
on average 10% when consumed in amounts of 2 g/day
[20]. This cholesterol lowering effect is additional to that
obtained with a low saturated fat diet or the use of
statins. With respect to the cardiovascular risk level
(SCORE) in the present study, it would have been highenough to recommend the initiation of the intervention
strategies with dietary changes in almost all of the par-
ticipants [20,26]. Recent research has revealed that even
individuals with a low risk of vascular events benefit con-
siderably from intensive LDL cholesterol lowering [27].
Arterial health can be assessed with surrogate markers
evaluating arterial stiffness and endothelial function. Ar-
terial stiffness expressed as PWV and endothelial func-
tion measured as pulse wave amplitude during reactive
hyperemia are novel, non-invasive methods with which
to assess subclinical atherosclerosis, even to predict fu-
ture cardiovascular events [28,29]. The measurement of
endothelial function by PAT has recently been used in
nutrition-based interventions [30,31]. Arterial stiffness
and endothelial function evaluate different aspects of the
arterial wall and need not correlate with each other. In
the present study, RHI was not impaired in this popula-
tion and this parameter did not correlate with LDL chol-
esterol concentration, SCORE or with any of the dietary
variables. These results indicate that if one wishes to
undertake a comprehensive evaluation of vascular health
the surrogate markers both of endothelial function and
arterial stiffness are needed.
CAVI is an index of arterial stiffness in large arteries
reflecting the elastic properties of the arterial wall between
the aortic arch and the lower extremities [2-4]. CAVI in-
creases with age and in arteriosclerotic diseases, and is re-
lated to the serum LDL cholesterol concentration and to
elevated blood pressure [4]. CAVI was elevated in every
fifth male Finnish firefighter (mean age 48 yrs) [3]. Aer-
obic fitness in addition to age was correlated with CAVI
[3]. In the present study, which evaluated a slightly older
population of mainly white-collar employees, the fre-
quency of impaired CAVI was much greater. In addition
to age and the LDL cholesterol concentration, the value of
CAVI correlated with the SCORE. This finding suggests
that interventions should focus especially on those risk
factors which can be modified. In this study population
with rather well-controlled smoking and blood pressure, a
reduction in the LDL cholesterol concentration would be
of special importance. The observation that dietary choles-
terol intake was associated with CAVI is important be-
cause it connects the dietary habits to arterial well-being.
There are some limitations in this study. There were
four participants who had used plant sterol/stanol prod-
ucts before the study, but they were included in the
study after a 3 weeks’ wash out period, which is enough
for the serum cholesterol concentration to be restored
to its initial value [11,12]. Excluding these four individ-
uals from all statistical analyses did not change the re-
sults. In the cross-sectional study, data was collected
only at one time point, and thus it is difficult to prove
causalities for the associations found. In addition, the
study population was of limited size, they volunteered to
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extrapolate these results to the general population. How-
ever, the study population represented a homogenous
population of urban, well-educated, middle-aged partici-
pants interested in their health and well-being. Food re-
cording for three to four consecutive days has been
found to be sufficient to estimate the intake of energy
nutrients at a group level [32,33]. However, for the moni-
toring of cholesterol intake, more recording days may be
needed [32]. In general, energy intake as measured by diet-
ary records has been found to be 10-30% lower as com-
pared with total energy expenditure measured by doubly-
labeled water [34]. Because of the under-reporting, all the
intakes have been energy-adjusted, either as percentages
of energy or per MJ except for the cholesterol intake was
also expressed as mg/d and fiber intake as g/d.
Conclusions
In a cross-sectional study the majority of asymptomatic,
middle-aged participants had an elevated LDL choles-
terol concentration, increased arterial stiffness and poor
dietary habits with high intake of SFA. The novel obser-
vation that arterial stiffness was associated with dietary
cholesterol intake and SCORE emphasizes the urgency
of adequate lifestyle and dietary interventions to prevent
future coronary events.
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